You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amgen

Showing 1 - 25 of 1,427
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease Trial in Ho Chi Minh City (Stimus)

Active, not recruiting
  • Chronic Kidney Disease
  • Stimus
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Nov 23, 2022

Anemia, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Ho Chi Minh City (Stimus (NNG-DEPO))

Active, not recruiting
  • Anemia
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Stimus (NNG-DEPO)
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Jan 4, 2023

Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure Trial

Not yet recruiting
  • Heart Failure NYHA Class II
  • +2 more
    • (no location specified)
    May 22, 2023

    Colo-rectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

    Recruiting
    • Colo-rectal Cancer
    • therascreen® KRAS RGQ PCR Kit
    • Manchester, United Kingdom
      QIAGEN Gaithersburg, Inc
    Apr 20, 2022

    Acute Metabolic Effects of Evolocumab and Atorvastatin Trial (Evolocumab)

    Not yet recruiting
    • Acute Metabolic Effects of Evolocumab and Atorvastatin
    • (no location specified)
    Nov 16, 2023

    Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

    Not yet recruiting
    • Abdominal Aortic Aneurysm
    • (no location specified)
    Oct 12, 2023

    Neutropenia Trial in Montevideo (Pegfilgastrim Megalabs, Pegfilgastim Amgen)

    Recruiting
    • Neutropenia
    • Pegfilgastrim Megalabs
    • Pegfilgastim Amgen
    • Montevideo, Brazil
      Marcos Giusti
    Apr 8, 2022

    Heart Transplant Trial in Omaha (Evolocumab (Repatha))

    Active, not recruiting
    • Heart Transplant
    • Evolocumab (Repatha)
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Dec 15, 2022

    Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Rochester, New York
      University of Rochester
    Oct 3, 2022

    Psoriasis Trial in Winston-Salem (Otezla - Standard Care, Reminder Text Intervention with apremilast, Extended Consultation for

    Not yet recruiting
    • Psoriasis
    • Otezla - Standard Care
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Jan 31, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • Tampa, Florida
    • +2 more
    Feb 14, 2022

    Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebos)

    Active, not recruiting
    • Acute Coronary Syndrome
    • Baltimore, Maryland
      The Johns Hopkins Hospital
    Dec 8, 2022

    NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Stereotactic body radiation therapy (SBRT)
    • Temporary Stopping
    • Stockholm, Solna, Sweden
      Karolinska University Hospital
    Nov 9, 2023

    Premenopausal Idiopathic Osteoporosis Trial in New York (Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled

    Recruiting
    • Premenopausal Idiopathic Osteoporosis
    • Romosozumab Prefilled Syringe [Evenity]
    • Denosumab 60 MG/ML Prefilled Syringe [Prolia]
    • New York, New York
      Columbia University Irving Medical Center
    Oct 5, 2022

    Primary Hyperparathyroidism Trial in New York (Denosumab, Placebo)

    Terminated
    Has Results
    • Primary Hyperparathyroidism
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

    Not yet recruiting
    • Lymphoblastic Leukemia
    • Palo Alto, California
      Stanford University
    Apr 27, 2023

    Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 30, 2022

    NSCLC, Colorectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Colorectal Cancer
    • therascreen® KRAS RGQ PCR Kit
    • Manchester, United Kingdom
      QIAGEN Gaithersburg, Inc
    Apr 20, 2022

    Soft Tissue Sarcoma Trial in Iowa City (Talimogene Laherparepvec, Radiotherapy)

    Recruiting
    • Soft Tissue Sarcoma
    • Talimogene Laherparepvec
    • Radiotherapy
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 4, 2022

    Breast Cancer Trial in Stony Brook (Denosumab)

    Completed
    • Breast Cancer
    • Stony Brook, New York
      Stony Brook University Cancer Center
    Jan 19, 2022

    Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Aug 8, 2022

    Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

    Recruiting
    • Hyperlipidemias
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 18, 2022

    Fracture of Femur Trial in Barcelona (Pharmacological education, Training in the use of MyPlan Aplication, Patient Experience)

    Recruiting
    • Fracture of Femur
    • Pharmacological education
    • +2 more
    • Barcelona, Spain
      Hospital Clinic de Barcelona
    Dec 29, 2022

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Poitiers, France
      CHU Poitiers
    Jan 9, 2023

    Atopic Dermatitis Trial in Boston (Apremilast)

    Recruiting
    • Atopic Dermatitis
    • Boston, Massachusetts
      Tufts Medical Center, Department of Dermatology
    Jul 1, 2022